CMS Announces Details of Plan to Cover Alzheimer’s Drugs

On June 22nd, The Centers for Medicare and Medicaid Services (CMS) released details describing how Medicare beneficiaries can obtain Medicare-covered drugs that may slow the progression of Alzheimer’s disease. Medicare will cover drugs with traditional FDA approval when a physician and clinical team participates in the collection of evidence about how these drugs work, also known as a registry. To get Medicare coverage people will need to 1) be enrolled in Medicare, 2) be diagnosed with mild cognitive impairment or mild Alzheimer’s disease dementia, and 3) have a physician participating in a registry with an appropriate clinical team and follow-up care...